AMENDMENT TO SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • July 3rd, 2019 • Histogenics Corp • Orthopedic, prosthetic & surgical appliances & supplies • New York
Contract Type FiledJuly 3rd, 2019 Company Industry JurisdictionTHIS AMENDMENT TO SECURITIES PURCHASE AGREEMENT (this “Amendment”), is made and entered into as of June 28, 2019, by and among Ocugen, Inc., a Delaware corporation (“Ocugen”), Histogenics Corporation, a Delaware corporation (“Histogenics”), and the investor listed on the signature page attached hereto (the “Investor”). Capitalized terms used herein and not otherwise defined shall have the meanings assigned to such terms in that certain Securities Purchase Agreement, made and entered into as of June 13, 2019, by and among Ocugen, Histogenics, the Investor and the other investors (together with the Investor, the “Buyers”) listed on the Schedule of Buyers attached thereto (the “Agreement”).